GLG News by Psychiatrists

The article published in the www.fiercebiotech.com is a positive indication of Lilly's approach to treat Alzheimer's disease, with the invention of 'The IDENTITY Trial', in which the efficacy of LY450139, an investigational gamma secretase inhibitor for the treatment of mild to moderate Alzheimer's...

The article published in the www.pharmalive.com is presenting a very useful information for preventing common illness, such as cold sores. The successful clinical outcome from phase III trial for Lipsovir is a progressive step for Medivir to develop preventative medicine. Particularly,  the combination...

The article is showing good practice taken by both EMEA and CHMP to scrutinize the viablity of Cimzia® (certolizumab pegol) to treat Crohn's disease in the drug market. Although specific issues for rejection were not known, however, the article mentioned about UCB's ongoing attempt to get formal...

The article published in the www.pipelinereview.com is presenting the clinical efficacy of three new antibody-drug conjugates aimed at treating pancreatic, colon, and lung cancers. The chemical compunds of each of these drugs are designed to treat specific cancer without posing a threat to normal...

This article is enlighting our understanding of developing cardiovascular disease, depression and cancer for patients with Psoriasis. The report published in the www.pharmalive.com is an awareness review for Psoriasis, especially the implications for developing further serious medical conditions....

The article is presenting an overview of pharmaceutical and biotechnology companies active participation to  develop drugs based on immune medicine for a growing list of ailments, and successful outcomes are reported from growing rate of sale. The value of Immune factor drugs worldwide has...

This article is presenting an overview of performance from immune drugs to treat patients afflicted with heretofore intractable conditions. The promising growth in sale is showing the good prospect of serving as a impetus for further development for immune drugs.  The success of immune drugs has...

The article is showing a promising medical intervention to treat intracellular protein changes due to disease and ageing, at least for human population after a positive outcome obtained from a research with 88 men exposed to respiratory syncytial virussyncytial virus.  RNAi Drug is believed...

This article is showing the financial implications for publicising the safe-use of a drug. Lorcaserin, obesity drug has no major concern for heart-valve damage - this news from Arena Pharmaceuticals Inc. (ARNA) is opening up a good prospective for marketing Lorcaserin, and this has been compared...

The article is showing a promising outcome from a late stage clinical trial for Bosatria to reduce a a rare inflammatory condition. This is an added clinical outcome for Bostaria which was originally developed for the treatment of allergic asthma and atopic dermatitis. While 95% of the total 85...